Investors focused on the Medical space have likely heard of Aeglea BioTherapeutics (AGLE), but is the stock performing well in comparison to the rest of its sector peers? Let's take a closer look at ...

Aeglea BioTherapeutics, Inc. AGLE announced a corporate restructuring plan to focus resources and prioritize the development of its pipeline candidate, AGLE-177 for the treatment of patients living ...

In this article we will take a look at whether hedge funds think Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) is a good investment right now. We check hedge fund and billionaire investor sentiment ...

Based on the fact that hedge funds have collectively under-performed the market for several years, it would be easy to assume that their stock picks simply aren’t very good. However, our research ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

*The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once the company announces the ...